GNPX LONG OR BUY THE STOCK PRICE IS AT $3.60 UP 55.84% TODAY
Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
Tuesday morning Genprex announced an expansion of 16 additional exclusive worldwide patent and tech licensing agreements with MD Anderson for Oncoprex. This will allow the company to potentially expand its pipeline to include trials with Tagrisso, Keytruda, Opdivo, and Yervoy, among other combinations. That puts Merck (MRK) , AstraZeneca (AZN) , and Bristol-Myers Squibb (BMY) on the frontline as potential suitors, in my view.
I BOT 2 contracts of the $2.50 Call expiration 5/15/2020 for $254. I plan to close by the 14th because Earnings are due on the 15th. You can buy the $2.50 Call or buy the stock. The next call is the $5.00 call.
Tuesday morning Genprex announced an expansion of 16 additional exclusive worldwide patent and tech licensing agreements with MD Anderson for Oncoprex. This will allow the company to potentially expand its pipeline to include trials with Tagrisso, Keytruda, Opdivo, and Yervoy, among other combinations. That puts Merck (MRK) , AstraZeneca (AZN) , and Bristol-Myers Squibb (BMY) on the frontline as potential suitors, in my view.
I BOT 2 contracts of the $2.50 Call expiration 5/15/2020 for $254. I plan to close by the 14th because Earnings are due on the 15th. You can buy the $2.50 Call or buy the stock. The next call is the $5.00 call.
Kommentar:
I realize GNPX is down .26 today, however the S&P, GOLD, OIL and many stocks are down also. GNPX still has Strong "buy" signals, try to hang in there, it is a bumpy ride out there today.